You are here
Regular oral use of smokeless tobacco
Malignant neoplasm of the oral cavity and oropharynx and hypopharynx - Regular oral use of smokeless tobacco Factor
Last reviewed for CCPS 05 October 2005.
Investigative Documents
Claimant Report - Oral Use of Smokeless Tobacco - Malignant Neoplasm of the Oral Cavity, Oropharynx and Hypopharynx [CR9161] Preliminary questions [14355]
15771 the veteran has engaged in the oral use of smokeless tobacco on more days than not for an extended period at some time. 15773 — the veteran has established the causal connection between the oral use of smokeless tobacco and VEA service for the clinical onset of the malignant neoplasm of the oral cavity, oropharynx or hypopharynx. 15776 — the veteran has established the causal connection between the oral use of smokeless tobacco and operational service for the clinical onset of the malignant neoplasm of the oral cavity, oropharynx or hypopharynx. or 15778 — the veteran has established the causal connection between the oral use of smokeless tobacco and eligible service for the clinical onset of the malignant neoplasm of the oral cavity, oropharynx or hypopharynx. Clinical onset and operational service [15776] Clinical onset and eligible service [15778]